2026 NPPES data Cardiovascular Disease Physician NPI 1457507915 M.D.
Verify on CMS →

FARAMARZ TEHRANI, M.D.

Cardiovascular Disease Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
465
Medicare Part D claims · 89 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$205.9
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

FARAMARZ TEHRANI, M.D. filed 465 Medicare Part D claims in 2023 as a Cardiovascular Disease Physician in LOS ANGELES, California, prescribing 76% generic.

465
Part D claims, 2023
76%
generic prescribing
$205.9
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

FARAMARZ TEHRANI, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

465 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

FARAMARZ TEHRANI, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about FARAMARZ TEHRANI, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/14/2008

NPI 1457507915

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

465 85% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

Specialty distribution in California

How Cardiovascular Disease Physician compares to other specialties among California providers

California providers

Cardiovascular Disease Physician share within California

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Cardiovascular Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Cardiovascular Disease Physician ABMS/AOA estimate

Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

FARAMARZ TEHRANI, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 1513 S GRAND AVE, LOS ANGELES, CA, 90015, with a listed phone of (213) 742-6400. NPI 1457507915 was issued on 08/14/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TEHRANI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 465 prescription claims written by this provider, covering 89 Medicare beneficiaries and totaling roughly $97K in drug spend, split 24% brand-name and 76% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1513 S GRAND AVE
LOS ANGELES, CA 90015

Provider Details

NPI 1457507915
Specialty Cardiovascular Disease Physician
Credentials M.D.
Gender Male
NPI Issued 08/14/2008

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for FARAMARZ TEHRANI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$206

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to FARAMARZ TEHRANI, M.D.. To verify FARAMARZ TEHRANI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

FARAMARZ TEHRANI, M.D. — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 465 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

465
Total Claims
$97K
Total Drug Cost
89
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,020
Total Day Supply
30,584
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$85K
Generic Drug Cost
$13K

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
1.96
Gender Split
46% female / 54% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What FARAMARZ TEHRANI, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
51
Jardiance
Empagliflozin
42
Eliquis
Apixaban
39
Clopidogrel
Clopidogrel Bisulfate
38
Carvedilol
36
Metoprolol Tartrate
32
Isosorbide Mononitrate Er
Isosorbide Mononitrate
30
Amlodipine Besylate
27
Hydralazine Hcl
27
Metoprolol Succinate
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How FARAMARZ TEHRANI, M.D. fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

FARAMARZ TEHRANI, M.D.'s 465 claims are below the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as TEHRANI.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is FARAMARZ TEHRANI, M.D.'s specialty?
FARAMARZ TEHRANI, M.D. specializes in Cardiovascular Disease Physician and practices in LOS ANGELES, California. Credentials: M.D..
How much does FARAMARZ TEHRANI, M.D. prescribe under Medicare Part D?
In 2023, FARAMARZ TEHRANI, M.D. wrote 465 Medicare Part D claims totaling $97K in drug costs for 89 beneficiaries.
Where is FARAMARZ TEHRANI, M.D. located?
FARAMARZ TEHRANI, M.D. is located at 1513 S GRAND AVE, LOS ANGELES, CA, 90015. Phone: (213) 742-6400.
What is FARAMARZ TEHRANI, M.D.'s NPI number?
FARAMARZ TEHRANI, M.D.'s National Provider Identifier (NPI) is 1457507915, issued on 08/14/2008.
Does FARAMARZ TEHRANI, M.D. prescribe more brand-name or generic drugs?
FARAMARZ TEHRANI, M.D.'s prescribing is 24% brand-name and 76% generic drugs by claim count, with $85K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does FARAMARZ TEHRANI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, FARAMARZ TEHRANI, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Jardiance, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does FARAMARZ TEHRANI, M.D. accept Medicare?
FARAMARZ TEHRANI, M.D. appears in CMS Medicare data with 465 Part D claims and 89 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify FARAMARZ TEHRANI, M.D.'s credentials?
FARAMARZ TEHRANI, M.D.'s NPI is 1457507915 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology